NASHVILLE, Tenn. / Jan 04, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 4Q Earnings Release Call |
When: | Tuesday, January 30, 2024 at 9:00 am central (10:00 am eastern) |
How: | Live Audio over the Internet: |
https://investor.hcahealthcare.com/events-and-presentations/default.aspx | |
Contact
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$302.82 |
| Daily Change: | -8.43 -2.71 |
| Daily Volume: | 2,113,896 |
| Market Cap: | US$76.700B |
October 25, 2024 October 17, 2024 July 23, 2024 April 26, 2024 | |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MORE
C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...
CLICK TO LEARN MORE
